Implementation of Hysteroscopy in Flanders and the Netherlands

July 19, 2019 updated by: University Ghent
By means of a questionnaire the investigators will study the implementation of hysteroscopy in Flanders and the Netherlands

Study Overview

Detailed Description

Hysteroscopy is a minimally invasive method for diagnosis and treatment of intra-uterine abnormalities. Complication and failure rates are low because of the direct visualisation of the treated abnormality. Moreover, hysteroscopic procedures replaced 'blind' (curettage) and more invasive interventions (hysterectomy).

The field of hysteroscopy has developed over the years. Changes occurred in hysteroscopic instruments and in the use of energy sources. An important development is the smaller diameter of the hysteroscopic system which makes it suitable for an outpatient setting. Not every gynaecologist, however, has the appropriate hysteroscopic skills or setting to carry out these procedures.

The incorporation of hysteroscopic procedures into daily practice in Flanders is unclear. In the Netherlands 2 surveys were conducted in the past to question the treatment options for polypectomy in an outpatient setting on the one hand and the diffusion of hysteroscopy on the other hand.

The investigators want to study the diffusion of hysteroscopy in Flanders and the Netherlands. Moreover the investigators want to provide an overview of the hysteroscopic procedures implemented, as well as the setting they are performed in.

An electronic questionnaire (LimeService) will be sent to all gynaecologists in Flanders and the Netherlands. Participation is voluntary and anonymous. After informed consent all gynaecologists are asked to complete the first part of the questionnaire containing general information. The second part is specific for gynaecologists performing hysteroscopy themselves, and inquires about the procedures they carry out.

Study Type

Observational

Enrollment (Actual)

249

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Recognized gynaecologists (members of the Flemisch Society of Obstetricians and Gyneacologists (VVOG) and members of the Dutch Society of Obstetricians and Gyneacologists (NVOG))

Description

Inclusion Criteria:

  • gynaecologist

Exclusion Criteria:

  • residents in training for gynaecology/obstetrics

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Questionnaire: Implementation of hysteroscopy
Time Frame: August 2016, questionnaire will be sent once at the start of the study
the amount of gynaecologists performing hysteroscopy in relation to the total of gynaecologists participating in the questionnaire
August 2016, questionnaire will be sent once at the start of the study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Questionnaire: setting for performing diagnostic hysteroscopy
Time Frame: August 2016, questionnaire will be sent once at the start of the study
in which setting (office/operating room) diagnostic hysteroscopies are performed in relation to the total amount of diagnostic hysteroscopies performed
August 2016, questionnaire will be sent once at the start of the study
Questionnaire:Instrumentation used for hysteroscopy
Time Frame: August 2016, questionnaire will be sent once at the start of the study
which instrumentation is used for specific hysteroscopic procedures.
August 2016, questionnaire will be sent once at the start of the study
Questionnaire: Diagnostic and techniques in the treatment of intrauterine pathology
Time Frame: August 2016, questionnaire will be sent once at the start of the study
which diagnostics and techniques are used in the treatment of intrauterine pathology
August 2016, questionnaire will be sent once at the start of the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Tjalina Hamerlynck, Ghent University Hostpital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2016

Primary Completion (ACTUAL)

June 1, 2017

Study Completion (ACTUAL)

June 1, 2017

Study Registration Dates

First Submitted

July 19, 2016

First Submitted That Met QC Criteria

July 29, 2016

First Posted (ESTIMATE)

August 3, 2016

Study Record Updates

Last Update Posted (ACTUAL)

July 22, 2019

Last Update Submitted That Met QC Criteria

July 19, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myoma

Subscribe